DK2822568T3 - Anvendelser af caseinsammensætninger - Google Patents

Anvendelser af caseinsammensætninger Download PDF

Info

Publication number
DK2822568T3
DK2822568T3 DK13757439.8T DK13757439T DK2822568T3 DK 2822568 T3 DK2822568 T3 DK 2822568T3 DK 13757439 T DK13757439 T DK 13757439T DK 2822568 T3 DK2822568 T3 DK 2822568T3
Authority
DK
Denmark
Prior art keywords
case compositions
compositions
case
Prior art date
Application number
DK13757439.8T
Other languages
English (en)
Inventor
Aaron Calvin Fanning
Hasmukh Ambalal Patel
Johannes Schalk
Ramon Stafford Hall
Roger Richard Schwarzenbach
Sergey Yevgenievich Ukraintsev
Original Assignee
Fonterra Co-Operative Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49117099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2822568(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fonterra Co-Operative Group Ltd filed Critical Fonterra Co-Operative Group Ltd
Application granted granted Critical
Publication of DK2822568T3 publication Critical patent/DK2822568T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Water Supply & Treatment (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
DK13757439.8T 2012-03-09 2013-03-11 Anvendelser af caseinsammensætninger DK2822568T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261608858P 2012-03-09 2012-03-09
PCT/NZ2013/000035 WO2013133727A1 (en) 2012-03-09 2013-03-11 Uses of casein compositions

Publications (1)

Publication Number Publication Date
DK2822568T3 true DK2822568T3 (da) 2020-08-10

Family

ID=49117099

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13757439.8T DK2822568T3 (da) 2012-03-09 2013-03-11 Anvendelser af caseinsammensætninger

Country Status (13)

Country Link
US (3) US20150011468A1 (da)
EP (1) EP2822568B1 (da)
JP (1) JP6420156B2 (da)
CN (1) CN104159592B (da)
AU (1) AU2013202942B2 (da)
DK (1) DK2822568T3 (da)
ES (1) ES2811759T3 (da)
HR (1) HRP20201197T1 (da)
HU (1) HUE050010T2 (da)
LT (1) LT2822568T (da)
NZ (1) NZ700686A (da)
PL (1) PL2822568T3 (da)
WO (1) WO2013133727A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
CA2971806C (en) * 2014-12-26 2022-05-03 Compagnie Gervais Danone Product comprising a container and whey protein
WO2016190750A1 (en) * 2015-05-22 2016-12-01 The A2 Milk Company Limited Beta-casein a2 and antioxidant capacity
TWI761487B (zh) * 2017-04-06 2022-04-21 日商明治股份有限公司 用於促進血中胺基酸濃度上升之發酵乳
WO2019086407A1 (en) 2017-10-30 2019-05-09 Frieslandcampina Nederland B.V. Protein-dense nutritional compositions for use in treating and/or preventing a condition linked to loss of muscle mass and/or strength
EP4696147A3 (en) 2018-11-20 2026-04-22 Fonterra Co-Operative Group Ltd Dairy product and process
WO2020236772A1 (en) * 2019-05-20 2020-11-26 Rummel Iii Kirk Enhanced coffee or tea
JP7817153B2 (ja) * 2020-04-13 2026-02-18 合同酒精株式会社 発酵乳及びその製造方法、並びに脱リン酸乳
US20210352938A1 (en) * 2020-05-12 2021-11-18 Raymond L. Sullivan, JR. Novel drink
US20220030923A1 (en) * 2020-07-17 2022-02-03 Northern Innovations Holding Corp. Caffeine and Alpha Lipoic Acid Compositions for Enhanced Sensory Effects
IL276823A (en) * 2020-08-19 2022-03-01 Re Milk Ltd Casein formulations and their use
CN114304369A (zh) * 2020-09-29 2022-04-12 内蒙古伊利实业集团股份有限公司 一种乳清蛋白组合物及其制备方法和应用
US20220225640A1 (en) * 2021-01-19 2022-07-21 Alexia Ramos Multipurpose Beverage Composition
WO2022225770A1 (en) * 2021-04-19 2022-10-27 Abbott Laboratories High protein liquid nutritional compositions
CN116210914A (zh) * 2023-03-02 2023-06-06 中国农业大学 一种胶束酪蛋白-花色苷复合物粉体组合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501675A (en) * 1999-12-09 2002-12-20 New Zealand Dairy Board Translucent milk drink having a pH of 5.7 to 7.0 and a percentage transmission of at least 5% prepared by a cation exchange process
NZ501676A (en) * 1999-12-09 2002-12-20 New Zealand Dairy Board Calcium-depleted milk protein products and use in cheese manufacture to reduce nugget-formation
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
NZ523394A (en) * 2002-12-24 2006-03-31 New Zealand Dairy Board Dairy protein processing and applications thereof
WO2010126353A1 (en) 2009-04-27 2010-11-04 N.V. Nutricia Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
AU2011210764A1 (en) * 2010-01-29 2012-07-05 Abbott Laboratories Nutritional emulsions comprising calcium HMB and soluble protein
DK2592938T4 (da) * 2010-07-16 2025-01-02 Fonterra Cooperative Group Ltd Mejeriprodukt og fremgangsmåde

Also Published As

Publication number Publication date
HUE050010T2 (hu) 2020-11-30
ES2811759T3 (es) 2021-03-15
NZ700686A (en) 2016-08-26
WO2013133727A1 (en) 2013-09-12
US20170232063A1 (en) 2017-08-17
AU2013202942A1 (en) 2013-09-26
HRP20201197T1 (hr) 2020-11-13
EP2822568B1 (en) 2020-06-17
EP2822568A4 (en) 2015-11-11
CN104159592B (zh) 2018-10-19
US20190105371A1 (en) 2019-04-11
JP2015509531A (ja) 2015-03-30
HK1205947A1 (en) 2015-12-31
EP2822568A1 (en) 2015-01-14
JP6420156B2 (ja) 2018-11-07
CN104159592A (zh) 2014-11-19
AU2013202942B2 (en) 2016-05-12
PL2822568T3 (pl) 2020-11-16
US20150011468A1 (en) 2015-01-08
LT2822568T (lt) 2020-09-10

Similar Documents

Publication Publication Date Title
DK3725778T4 (da) Formuleringer af enzalutamid
SMT201700094B (it) Composto di pirazina carbossammide
EP2736491A4 (en) BEPOTASTIN COMPOSITION
LT2791160T (lt) Modifikuotos mrnr sudėtys
DK3156056T3 (da) Farmaceutiske sammensætninger der består af sorbitanestere
EP2675909A4 (en) GLUCOSYLSTEVIA COMPOSITION
EP2720561A4 (en) Stevia-COMPOSITION
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK2911506T3 (da) Driftreducerende sammensætninger
EP2713762A4 (en) Stevia-COMPOSITION
DK3461895T3 (da) Modulation af ube3a-ats-ekspression
EP2912131A4 (en) Adhesive compositions
BR112015002651A2 (pt) composições cosméticas
BR112014032798A2 (pt) composição
CO6930368A2 (es) Composiciones de yodo-povidona estable
ME03413B (me) Kompozicije које sadrže peg i askorbat
BR112015003038A2 (pt) composições lubrificantes
EP2900621A4 (en) BIOKERAMIKZUSAMMENSETZUNGEN
DK3106150T3 (da) Forbedrede farmaceutiske sammensætninger af pimobendan
DK2822967T3 (da) Compositions comprising secretory - like immunoglobulins
EP2857472A4 (en) ADHESIVE COMPOSITION
DK2800572T3 (da) Sammensætning af ellagitannin-rige ekstrakter
DK2919777T3 (da) Transmukosal afgivelse af tocotrienol
DK2925338T3 (da) Frysetørret formulering af tat-nr2b9c
DK2854831T3 (da) Fremstilling af degarelix